Patheon - Drug Development & Manufacturing Services

Thermo Fisher Scientific to Acquire Manufacturing Site in Cork, Ireland

We are excited to announce our intent to acquire an API manufacturing site in Cork, Ireland, from GlaxoSmithKline. Read the press release to learn more about how this new addition to our global site network will help expand and strengthen our API capabilities.

Read Full Press Release »

From Molecule to Medicine. Pharma Services is Your Partner for Every Step.

Thermo Fisher Scientific’s Pharma Services business delivers the most complete, end-to-end, contract development and manufacturing, viral vector development and manufacturing, logistics services and clinical trial solutions for pharma and biotech companies of all sizes. Learn more about our capabilities and how we can take your discovery from clinical to commercial.

Learn More About Our Integrated Capabilities »

Yoonhee Ko
Senior Business
Development Manager,
Pharma Services,
South Korea

Solved
With

POWER & PROCESS

Read Stories About Our People »

Unmatched, Fully Integrated Global Network

Our global network of pharmaceutical development and manufacturing facilities allows Thermo Fisher Scientific the collaboration and reach to ensure your project gets completed quickly and accurately.

Learn More About Our Sites »

Our Capabilities

Small Molecule Development

From route scouting to analytical development & validation, our experts pride themselves on solving your small molecule API development challenges.

Large Molecule Development

We offer comprehensive development and clinical manufacturing services for biologics, ranging from cell line development to cold storage and distribution.

Commercial Manufacturing

We develop or manufacture more than 1,000 large and small molecule products, approved for more than 70 countries. But success isn’t just about scale, it also reflects our ability to deliver exceptional quality and service.

Oral Solid Dose

Every pharmaceutical product presents unique manufacturing challenges, which is why we offer an expansive range of choices in oral solid dosage forms and technologies.

Steriles

We have extensive sterile injectable product development capabilities for liquid-filled and lyophilized vials, including world-class expertise in lyophilization and for pre-filled syringes and cartridges.

Softgel Medication Capsules Manufacturing

Softgels

Softgel technologies are an increasingly popular dosage form in both the prescription (Rx) and OTC markets. Learn more about the many benefits of softgel technology.

Featured Whitepapers & Brochures

Getting to First-in-Human Clinical Trials: A Make-or-Break Milestone for Small Biopharmas

“Faster and better” has become the mantra for biopharmaceutical companies as they face intense pressure to get therapies to market quicker than ever before. The incentive of securing market share with first-to-market offerings is felt by all industry ..

Download

Six API Challenges That Could be Slowing Your Development and How to Avoid Them

The challenges for new drugs looking to enter the market are numerous and varied. But many are self-inflicted – especially in small molecule development. A dangerous perception persists that aside from highly potent APIs, small molecule medications have ..

Download

Molecule to Medicine Patheon FisherClinicalServices Overview Brochure

Pharma Services Overview Brochure

Patheon, by Thermo Fisher Scientific, is transforming the way pharmaceuticals are made with a simplified, end-to-end supply chain for pharmaceutical and biopharmaceutical companies of all sizes. Drug substances and drug products. ...

Download

Events

03 July, 2019

BioPharma Expo 2019 in Japan BioPharma Expo 2019 in Japan Place: Aomi Exhibition Hall, Tokyo Big Sight, Japan Date : July 3-5, 2019 (Patheon booth #A8-45) Don’t miss 3 of Patheon presentations on CDMO/Biologics services! “How to Strategically Fast Track your Biologic using CDMOs” Exhibitor presentation (3 speaking slots on July 3rd & July 4th) July 3 ( 13:40 –14:40… Read More

10 September, 2019

Nordic Life Science Days Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science industry. Since its inception in 2013, the event has nurtured a community of people from the world of life science, and created a unique place to do business. Most attendees express their delight in the informal atmosphere, combined with an organised approach to meeting highly relevant people. Return visitors come back because they feel they belong to our growing community. We hope to welcome you, too. We create a space for meaningful encounters, with one-on-one meetings being one of the main features of NLSDays. Additionally, the high quality of topics and presenters provide insight into the most recent trends in science and business. NLSDays attracts leading decision makers from biotech, pharma and medtech as well as finance, research, policy and regulatory authorities.

News

May 16, 2019

Thermo Fisher Scientific to Acquire Manufacturing Site in Cork, Ireland, from GSK

May 1, 2019

Thermo Fisher Scientific Completes Acquisition of Brammer Bio

March 25, 2019

Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in Viral Vector Manufacturing

Patheon Visit us on LinkedIn

Patheon·

6/25/2019

“[Our] new suite of biomanufacturing solutions provides both flexible and scalable capacity to pharmaceutical and biotech companies that can speed time to market." Here's how a flexible business model helps clients get to market more quickly: http://bit.ly/2WYmckE #CDMO

Patheon·

6/21/2019

"Thermo Fisher Scientific is really all about serving our customers. And it starts with our mission that's about enabling our customers to make the world healthier, cleaner, and safer." Michel Lagarde explains how we put our clients at the center of everything: http://bit.ly/2KJyYfn #MadeWith

Patheon·

6/19/2019

"For us, consolidation has contributed to our growth by enabling us to offer a broader talent base for small biotechs to leverage, and based on feedback from our customers, they prefer to reduce the number of contract companies with which they are affiliated because working with multiple CDMOs/CROs is a resource drain." More from Paul Jorjorian on CDMO trends: http://bit.ly/2KcgmoF

PatheonFollow

Patheon@Patheon·

24 Jun

We believe listening and understanding is key to creating a positive client experience and finding the right solution. https://t.co/4KFjVkW67z #MadeWith

Reply on Twitter 1143229065454919680 Retweet on Twitter 11432290654549196801 Like on Twitter 11432290654549196801 Twitter 1143229065454919680

Patheon@Patheon·

21 Jun

Meet our oral solid dose and early development team in Milton Park. Their expertise in early stage, Phase 1 clinical trials makes them a perfect partner for small and emerging #pharma companies. https://t.co/qH4r19HPub

Reply on Twitter 1142171604870488064 Retweet on Twitter 1142171604870488064 Like on Twitter 11421716048704880641 Twitter 1142171604870488064

Patheon@Patheon·

20 Jun

Where is the #CDMO industry headed? Paul Jorjorian, VP and General Manager, Biologics, and other industry experts weigh in on what's next: https://t.co/1FkaHuQeBC via @GENbio

Reply on Twitter 1141803938557116418 Retweet on Twitter 11418039385571164181 Like on Twitter 11418039385571164182 Twitter 1141803938557116418

Drug Substance

Drug Product

Small Molecule API Development

Oral Solid Dose

Softgels

Large Molecule Biologics Development

Steriles

Innovative Solutions

Drug Substance

Drug Product

Small Molecule API Commercialization

Oral Solid Dose

Softgels

Large Molecule Biologics Commercialization

Steriles

Innovative Solutions

Thermo Fisher Scientific to Acquire Manufacturing Site in Cork, Ireland

From Molecule to Medicine. Pharma Services is Your Partner for Every Step.

Unmatched, Fully Integrated Global Network

Our Capabilities

Small Molecule Development

Large Molecule Development

Commercial Manufacturing

Oral Solid Dose

Steriles

Softgels

Meet the People of Patheon

Featured Whitepapers & Brochures

Getting to First-in-Human Clinical Trials: A Make-or-Break Milestone for Small Biopharmas

Six API Challenges That Could be Slowing Your Development and How to Avoid Them

Pharma Services Overview Brochure

Events

News